Bank of Nova Scotia »

Relmada Therapeutics shares owned by Bank of Nova Scotia

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Bank of Nova Scotia from 13F filings

Historical chart of Bank of Nova Scotia investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Bank of Nova Scotia consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Bank of Nova Scotia

Quarter filed Position value Share count Share price at filing
2026-03-31 $213k 31k 6.96

More positions owned by Bank of Nova Scotia

NVIDIA Corporation (NVDA)
Key (KEY)
Apple (AAPL)
Rbc Cad (RY)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p500 Etf (IVV)
Cibc Cad (CM)
Alphabet Cap Stk Cl C (GOOG)
Toronto Dominion Bk Ont Com New (TD)
JPMorgan Chase & Co. (JPM)
Bank Of Montreal Cadcom (BMO)
Tesla Motors (TSLA)

View all positions for Bank of Nova Scotia

Top funds holding Relmada Therapeutics

Henderson Group
Squadron Capital Management
VR Adviser
Adage Capital Partners GP
OrbiMed Advisors
Marshall Wace
Millennium Management
Vanguard Capital Management
RA Capital Management
Ikarian Capital
Driehaus Capital Management
Polar Capital Holdings
Susquehanna International
BlackRock
Vanguard Group

View all funds holding Relmada Therapeutics